NEW YORK, NY / ACCESSWIRE / August 28, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Karyopharm Therapeutics Inc (NASDAQGS:KPTI)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/karyopharm-therapeutics-inc-loss-submission-form?prid=3229&wire=1
Lead Plaintiff Deadline: September 23, 2019
Class Period: on behalf of shareholders of Karyopharm Therapeutics Inc. who: (1) purchased shares of Karyopharm’s common stock between March 2, 2017 and February 22, 2019, inclusive; (2) purchased Karyopharm shares in or traceable to the Company’s public offering of common stock conducted on or around April 28, 2017; or (3) purchased Karyopharm shares in or traceable to the Company’s public offering of common stock conducted on or around May 7, 2018.

Allegations against KPTI include that: Throughout the Class Period, the Company continued to tout the commercial prospects for selinexor and consistently described selinexor as having a “predictable and manageable tolerability profile” and a “very nice safety profile,” and assured investors that it was “well tolerated” by patients. Karyopharm also claimed that selinexor had the potential to be used as a new treatment for MM, with limited and manageable side effects. As a result of these misrepresentations, Karyopharm shares traded at artificially inflated prices during the Class Period.

2U, Inc. (NASDAQGS:TWOU)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/2u-inc-loss-submission-form?prid=3229&wire=1
Lead Plaintiff Deadline: October 7, 2019
Class Period: February 26, 2018 to July 30, 2019

Allegations against TWOU include that: (a) 2U’s business model was fundamentally flawed because the Company’s costs were growing disproportionately as it grew in size and complexity; (b) 2U could not take advantage of the promised economies of scale because its costs to attract each marginal student were actually increasing, not decreasing, as represented; (c) 2U was facing heightened competitive headwinds as alternative offerings flooded the marketplace and universities developed online courses in-house; (d) 2U’s growth rate in student enrollment was decelerating and was poised to decline as the Company reached market saturation; (e) 2U’s growth strategy was unsustainable, as the Company faced accelerating costs and had insufficient capital to achieve positive cash flows, improve margins or continue its revenue growth; and (f) as a result of (a)-(e), above, Defendants lacked any reasonable basis to issue 2U’s projections and financial forecasts.

Valaris plc (NYSE:VAL)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/valaris-plc-loss-submission-form?prid=3229&wire=1
Lead Plaintiff Deadline: October 21, 2019
Class Period: April 11, 2019 to July 31, 2019

Allegations against VAL include that: (i) the Company was plagued by a weak ultra-deepwater segment, massive cash usage, and significant negative cash flow; (ii) the foregoing was reasonably likely to have a material negative impact on the Company’s second quarter 2019 results; (iii) the merger leading to Valaris’s establishment could not deliver on its touted benefits; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 557739

NEW YORK, NY / ACCESSWIRE / August 28, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Venator Materials PLC (NYSE: VNTR)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/venator-materials-plc-loss-submission-form?prid=3228&wire=1
Lead Plaintiff Deadline: September 30, 2019
Class Period: (a) between August 2, 2017 and October 29, 2018, inclusive; (b) in or traceable to the Company’s initial public offering conducted on or around August 3, 2017; and (c) in or traceable to the Company’s secondary public offering conducted on or around December 4, 2017.

Allegations against VNTR include that: (a) the fire damage at the Pori facility was far more extensive than disclosed to investors, rendering the facility beyond repair; (b) the true cost of the Pori facility fire exceeded $1 billion, hundreds of millions of dollars beyond the limits of the Company’s insurance policy; (c) the Company was paying rebuilding premiums, and thereby incurring tens of millions of dollars in additional costs, in a futile attempt to expedite the rehabilitation process; (d) Venator had lost, essentially without prospect of rehabilitation, 80% of the production capacity of the Pori facility, and thus lost a substantial portion of one of its largest revenue producing assets; and (e) the Company’s reported annual Titanium Dioxide production capacity had been inflated by approximately 104,000 metric tons, or 15%.

GTT Communications, Inc. (NYSE: GTT)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/gtt-communications-inc-loss-submission-form?prid=3228&wire=1
Lead Plaintiff Deadline: September 30, 2019
Class Period: February 26, 2018 to July 1, 2019

Allegations against GTT include that: (1) following GTT’s acquisition of Interoute Communications Holdings S.A., there were delays in migrating Interoute’s legacy systems and processes into GTT’s client management database system; (2) Interoute had made a strategic priority shift to sell cloud services that was a higher percentage of Interoute’s sales in the two years leading up to the acquisition; (3) a material percentage of the Interoute sales representatives were not productive at selling GTT’s core cloud networking services; (4) GTT was unable to yield as many Interoute salespeople because Interoute had hired many sales people focused on cloud services and allowed underperforming sales representatives to remain at Interoute; and (5) as a result of the foregoing, Defendants’ public statements were materially false and/or misleading and/or lacked a reasonable basis.

International Flavors & Fragrances Inc. (NYSE: IFF)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/international-flavors-fragrances-inc-loss-submission-form?prid=3228&wire=1
Lead Plaintiff Deadline: October 11, 2019
Class Period: May 7, 2018 to August 5, 2019

Allegations against IFF include that: (1) that Frutarom Industries Ltd. (“Frutarom”), which the Company acquired in 2018, had bribed customers in Russia and Ukraine; (2) that senior management at Frutarom were aware of such improper payments; (3) that, as a result, Frutarom’s financial results were materially overstated; (4) that, as a result of the improper payments, the Company was reasonably likely to face regulatory scrutiny; (5) that the Company had not completed adequate due diligence before acquiring Frutarom; (6) that, as a result of the foregoing, the Company was unlikely to achieve purported synergies from the acquisition; and (7) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 557738

NEW YORK, NY / ACCESSWIRE / August 28, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Netflix, Inc. (NASDAQGS: NFLX)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/netflix-inc-loss-submission-form?prid=3227&wire=1
Lead Plaintiff Deadline: September 20, 2019
Class Period: April 17, 2019 to July 17, 2019

Allegations against NFLX include that: (1) Netflix would not be able to gain its expected target number of new subscribers in the second quarter of 2019; (2) Netflix would also lose subscribers from the United States in the second quarter of 2019; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

Just Energy Group Inc. (NYSE: JE)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/just-energy-group-inc-loss-submission-form?prid=3227&wire=1
Lead Plaintiff Deadline: September 30, 2019
Class Period: November 9, 2017 to July 23, 2019

Allegations against JE include that: (1) the Company experienced customer enrollment and nonpayment issues; (2) as a result, the Company was reasonably likely to incur an impairment charge to its accounts receivable; (3) as a result, the Company lacked adequate internal control over its financial reporting; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Pluralsight, Inc. (NASDAQGS: PS)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/pluralsight-inc-loss-submission-form?prid=3227&wire=1
Lead Plaintiff Deadline: October 15, 2019
Class Period: August 2, 2018 to July 31, 2019

According to the filed complaint, the Company failed to disclose that Pluralsight was experiencing substantial delays in hiring and properly training the salesforce necessary to meet its lofty billing projections. In addition, the Company knew at the time of the March 2019 secondary public offering (“SPO”) that it was behind schedule onboarding new sales representatives, which was hurting the Company’s sales execution and preventing Pluralsight from meeting its high growth projections. Instead of disclosing such facts at the time of the SPO, and to cash-out at inflated prices, Defendants intentionally obscured and omitted this pertinent information from investors.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 557737

VANCOUVER, BC / ACCESSWIRE / August 28, 2019 / AZARGA URANIUM CORP. (TSX:AZZ)(OTCQB:AZZUF)(FRA:P8AA) (“Azarga Uranium” or the “Company”) has received notice that the United States Environmental Protection Agency (the “EPA”) has issued revised draft permits for the Company’s Dewey Burdock In-Situ Recovery Uranium Project (the “Dewey Burdock Project”). The revised draft permits incorporate comments submitted to the EPA on the original draft permits, including comments submitted by the Company. The revised draft EPA permits pertain to the Company’s planned Class III and Class V Underground Injection Control (“UIC”) activities.

Blake Steele, President and CEO, stated: “We are pleased that the revised draft EPA permits for the Company’s flagship Dewey Burdock Project address the majority of the comments submitted by the Company. This is a significant step towards the issuance of the final EPA permits and continues to advance the Dewey Burdock Project towards development. The Company remains focused on working with the EPA to obtain the final permits in the near-term.

In parallel with advancing our permitting initiatives, we expect to publish the results of an updated preliminary economic assessment in the fall of 2019 for the Dewey Burdock Project.”

The Class III and Class V UIC EPA permits represent one of the three major regulatory agency approvals required for the Dewey Burdock Project. The Company already holds a Source and Byproduct Materials License from the United States Nuclear Regulatory Commission (the “NRC”), which is another of the three major regulatory agency approvals required for the Dewey Burdock Project. As noted in the Company’s 1 May 2019 news release, the Company has the opportunity to resolve the only remaining NRC License contention in the fourth quarter of 2019.

With respect to the third major regulatory agency, the South Dakota Department of Environment and Natural Resources staff has recommended approval of the major state permits. The hearings to finalize the state permitting process have been deferred until the federal permits, namely those pertaining to the NRC and EPA, are issued.

According to the EPA’s public notice, the draft permits will be made available for public review and comment until 10 October 2019.

About Azarga Uranium Corp.

Azarga Uranium is an integrated uranium exploration and development company that controls eleven uranium projects and prospects in the United States of America (“USA”) (South Dakota, Wyoming, Utah and Colorado) and the Kyrgyz Republic, with a primary focus of developing in-situ recovery uranium projects in the USA. The Dewey Burdock in-situ recovery uranium project in South Dakota (the “Dewey Burdock Project”), which is the Company’s initial development priority, has received its Nuclear Regulatory Commission License and draft Class III and Class V Underground Injection Control (“UIC”) permits from the Environmental Protection Agency (the “EPA”) and the Company is in the process of completing other major regulatory permit approvals necessary for the construction of the Dewey Burdock Project, including the final Class III and Class V UIC permits from the EPA.

For more information please visit www.azargauranium.com.

Follow us on Twitter at @AzargaUranium.

For further information, please contact:

Blake Steele, President and CEO
+1 303 790-7528
E-mail: info@azargauranium.com

Disclaimer for Forward-Looking Information

Certain information and statements in this news release may be considered forward-looking information or forward-looking statements for purposes of applicable securities laws (collectively, “forward-looking statements”), which reflect the expectations of management regarding its disclosure and amendments thereto. Forward-looking statements consist of information or statements that are not purely historical, including any information or statements regarding beliefs, plans, expectations or intentions regarding the future. Such information or statements may include, but are not limited to, statements with respect to the issuance of the revised draft EPA permits being a significant step towards the issuance of the final EPA permits and continues to advance the Dewey Burdock Project towards development, the Company remaining focused on working with the EPA to obtain the final permits in the near-term, the Company having the opportunity to resolve the only remaining NRC License contention in the fourth quarter of 2019, the Company expecting to publish the results of an updated preliminary economic assessment in the fall of 2019 for the Dewey Burdock Project and Azarga Uranium’s continued efforts to obtain all major regulatory permit approvals necessary for the construction of the Dewey Burdock Project, including the final Class III and Class V UIC permits from the EPA. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits Azarga Uranium will obtain from them. These forward-looking statements reflect management’s current views and are based on certain expectations, estimates and assumptions, which may prove to be incorrect. A number of risks and uncertainties could cause actual results to differ materially from those expressed or implied by the forward-looking statements, including without limitation: the risk that the issuance of the revised draft EPA permits is not a significant step towards the issuance of the final EPA permits and does not advance the Dewey Burdock Project towards development, the risk that the Company does not obtain the final EPA permits in the near-term, the risk that the Company does not resolve the only remaining NRC License contention in the fourth quarter of 2019, the risk that the Company does not publish the results of an updated preliminary economic assessment in the fall of 2019 for the Dewey Burdock Project, the risk that Azarga Uranium does not obtain all major regulatory permit approvals necessary for construction of the Dewey Burdock Project, including the final Class III and Class V UIC permits from the EPA, the risk that such statements may prove to be inaccurate and other factors beyond the Company’s control. These forward-looking statements are made as of the date of this news release and, except as required by applicable securities laws, Azarga Uranium assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements. Additional information about these and other assumptions, risks and uncertainties are set out in the “Risks and Uncertainties” section in the most recent AIF filed with Canadian security regulators.

The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this News Release.

SOURCE: Azarga Uranium Corp.

ReleaseID: 557735

Newswire has been selected by 5 Technology Companies to help increase brand awareness, traffic, and sales in order to maintain focus on product innovation. Distributing the right message to the right audience at the right time through the right medium.

NEW YORK, NY / ACCESSWIRE / August 28, 2019 / ​​​Five technology companies offering innovative products for web hosting, electronic data capture, artificial intelligence, gaming software and supply chain management have selected Newswire’s Earned Media Advantage Guided Tour, software delivered as a service that provides customers the ability to distribute the right message to the right audience at the right time through the right medium. Newswire provides customers the media communications utility to leverage press releases to highlight the company’s mission, message, product innovation and competitive differentiation.

Erik Rohrmann, SVP and Chief Operating Officer indicated, “The driving force behind this offering is matching customer needs with an industry practice that is required to ensure Customer Success. Historically, this industry has been intent on selling software that customers have to evaluate, select, implement, and support themselves. We’ve simplified this complex process.”

According to Rohrmann, “The previous approach increases the risk to the customer, adds cost, requires staff, and delays time to market and along with value creation. The Earned Media Advantage Guided Tour eliminates these risks and associated costs while delivering a media communications utility that allows customers to deliver the right message to the right audience at the right time just like an electric utility delivering power to our homes.”

“All of our customers’ media communications requirements including press release and multimedia distribution are addressed simply and cost-effectively, allowing them to focus on making a difference with their technology innovation,” said Rohrmann.

Customers can now transform ‘owned’ media (press releases) into the ‘Earned Media Advantage’. Using the right strategies, customers can lower their costs of press releases, increase the value of each release, and lower paid-media costs while shortening the journey to achieve earned media mentions.

To ensure the success of the services, an expert Earned Media Advantage Strategist leads customers through the journey every step of the way. The journey is designed to empower the Earned Media Advantage by developing a plan that is based on a media communications survey that defines press release content value and distribution. Customers are also provided a media communications calendar, services to set up, operate and manage media databases, media monitoring alerts, statistical analysis, reporting and media room news collection and sharing to ensure Customer Success.

About Newswire

Newswire delivers press release and multimedia distribution software and services (SaaS) that empower the Earned Media Advantage: greater brand awareness, increased traffic, greater return on media and marketing communications spend and the competitive edge. With over a decade of experience, Newswire continues to provide its customers with the ability to deliver the right message to the right audience at the right time through the right medium.

To learn and experience Newswire, visit http://www.newswire.com.

Contact Information

Anthony Santiago
​Vice President of Marketing
Newswire
Office: 917-398-2622
anthony@newswire.com

SOURCE: Newswire

ReleaseID: 557732

NEW YORK, NY / ACCESSWIRE / August 28, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Diebold Nixdorf, Incorporated (NYSE:DBD)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/diebold-nixdorf-incorporated-loss-submission-form?prid=3226&wire=1.
Lead Plaintiff Deadline: September 3, 2019
Class Period: February 14, 2017 to August 1, 2018

Allegations against DBD include that: (1) as a result of the Wincor acquisition and related integration, the Company was less focused on its core business; (2) the Company expected certain customers would not renew their service contracts (i.e. contract runoff); (3) the Company was not adequately prepared to staff service technicians; (4) as a result of the expected contract runoff, the Company would suffer a shortage of adequately trained service technicians; (5) as a result, the Company would suffer margin pressure in its services segment; (6) as a result of the foregoing, the Company would lose market share; and (7) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

National General Holdings Corp. (NASDAQGS:NGHC)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/national-general-holdings-corp-loss-submission-form?prid=3226&wire=1.
Lead Plaintiff Deadline: September 23, 2019
Class Period: August 6, 2015 to August 9, 2017

Allegations against NGHC include that: (a) National General was perpetrating a massive forced-placed CPI scheme to fraudulently saddle its own customers with unwanted and unneeded automobile insurance policies that it had underwritten; (b) National General’s illicit conduct in foisting unwanted and unneeded automobile insurance on its customers had resulted in some of the victims being declared delinquent, suffering adverse impacts to their creditworthiness, and/or having their cars improperly repossessed; (c) National General was exposed to an extreme risk of regulatory scrutiny, legal risks, and reputational harm as a result of its participation in the forced placed CPI scheme; (d) the Company had failed to maintain effective internal controls over its financial reporting, including by failing to maintain formal documentation sufficient to reasonably ensure the accuracy of internal reporting and accounting procedures across much of its business, including with respect to insurance policy premiums; (e) the Company’s reported quarterly revenues and policy premiums were in part the product of a fraudulent forced-placed insurance scheme and were therefore artificially inflated and unsustainable; and (f) National General had in fact lost substantial business with Wells Fargo because Wells Fargo had terminated the forced-placed CPI scheme after concluding that it posed excessive reputational risk and legal exposure.

Mallinckrodt Public Limited Company (NYSE:MNK)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/mallinckrodt-public-limited-company-loss-submission-form?prid=3226&wire=1.
Lead Plaintiff Deadline: September 24, 2019
Class Period: February 28, 2018 to July 16, 2019

Allegations against MNK include that: (i) Acthar posed significant safety concerns that rendered it a non-viable treatment for ALS; (ii) accordingly, Mallinckrodt overstated the viability of Acthar as an ALS treatment; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 557730

NEW YORK, NY / ACCESSWIRE / August 28, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tencent Music Entertainment Group (“Tencent” or “the Company”) (NYSE:TME). Investors who purchased Tencent stock are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/tme.

The investigation concerns whether Tencent and certain of its officers and/or directors have violated federal securities laws.

On August 27, 2019, Bloomberg reported that the State Administration of Market Regulation, China’s antitrust authority, is investigating exclusive licensing deals between Tencent and major record labels including Universal Music Group, Sony Music Entertainment, and Warner Music Group. On this news, Tecent’s American depositary receipt price fell $0.92 per share, or 6.83%, to close at $12.57 per share on August 27, 2019.

If you are aware of any facts relating to this investigation, or purchased Tencent shares,you can assist this investigation by visiting the firm’s site: www.bgandg.com/tme. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 557731

NEW YORK, NY / ACCESSWIRE / August 28, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Oasmia Pharmaceutical AB (“Oasmia”) or the “Company”) (NASDAQ:OASM) of the September 27, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Oasmia stock or options between October 23, 2015 and July 9, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/OASM. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of all those who purchased Oasmia securities between October 23, 2015 and July 9, 2019 (the “Class Period”). The case, Mikhlin v. Oasmia Pharmaceutical AB, No. 1:19-cv-04349 was filed on July 29, 2019.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Oasmia engaged in improper relatedparty transactions with Alceco International S.A. and Ardenia Investment LTD, which were controlled by Defendant Aleksov and his former father-in-law; (2) due to those transactions, millions of Swedish kronor were not accounted for in Oasmia’s books; (3) transactions concerning Oasmia’s patents were also “carried out in a doubtful way;” and (4) as a result of the aforementioned misconduct, defendants’ statements about Oasmia’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Specifically, on June 28, 2019, Oasmia issued a press release that stated it was reporting suspicious transactions made between Oasmia and Alceco and Ardenia to the Swedish Economic Crime Authority and appointing a special examiner to review them.

On this news, Oasmia’s stock price fell from $1.34 on June 27, 2019 to $1.02 on June 28, 2019-a $0.32 or a 23.88% drop.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Oasmia’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 557600